Akorn Inc (AKRX)-Financial and Strategic SWOT Analysis Review

Akorn Inc (AKRX)-Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH57129FSA
  • |
  • Pages: 52
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Akorn Inc (AKRX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Akorn Inc (Akorn) is a pharmaceutical company which carries out the development, manufacturing and commercialization of generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers the products in various dosage forms including oral liquids, otics, ophthalmics, injectables, topicals, inhalants, and nasal sprays. It also offers contract manufacturing services. Akorn offers these products and services to physicians, surgery centers, clinics, optometrists, hospitals, long-term care, wholesalers, retail pharmacies, group purchasing organizations and other pharmaceutical companies. It operates manufacturing facilities in India and the US. The company has presence in the US, Canada, Mauritius, Luxembourg, Switzerland and India. Akorn is headquartered in Lake Forest, Illinois, the US.

Akorn Inc Key Recent Developments

Mar 01,2017: Akorn Provides Fourth Quarter and Full Year 2016 Results and Outlines Full Year 2017 Guidance

Dec 12,2016: Akorn Announces Completion of FDA Re-inspection of Decatur Facility

Nov 03,2016: Akorn Provides Third Quarter 2016 Results

Aug 18,2016: Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development

Aug 04,2016: Akorn Provides Second Quarter 2016 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Akorn Inc-Key Facts 5

Akorn Inc-Key Employees 6

Akorn Inc-Key Employee Biographies 7

Akorn Inc-Major Products and Services 8

Akorn Inc-History 10

Akorn Inc-Company Statement 13

Akorn Inc-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Joint Venture 15

Section 2-Company Analysis 17

Akorn Inc-Business Description 17

Akorn Inc-Corporate Strategy 18

Akorn Inc-SWOT Analysis 19

SWOT Analysis-Overview 19

Akorn Inc-Strengths 19

Akorn Inc-Weaknesses 20

Akorn Inc-Opportunities 21

Akorn Inc-Threats 22

Akorn Inc-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

Akorn Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Akorn Inc, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Mar 01, 2017: Akorn Provides Fourth Quarter and Full Year 2016 Results and Outlines Full Year 2017 Guidance 34

Dec 12, 2016: Akorn Announces Completion of FDA Re-inspection of Decatur Facility 36

Nov 03, 2016: Akorn Provides Third Quarter 2016 Results 37

Aug 18, 2016: Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development 38

Aug 04, 2016: Akorn Provides Second Quarter 2016 Results 39

May 16, 2016: Akorn Provides First Quarter 2016 Results 40

May 10, 2016: Akorn Completes 2014 Financial Statement Restatement and Reports Audited 2015 and Restated 2014 Results 42

Mar 22, 2016: Akorn Provides Preliminary Unaudited Full Year 2015 Financial Results and Issues 2016 Financial Guidance 44

Mar 07, 2016: Akorn Receives Expected Additional Delinquency Notice From Nasdaq 46

Jan 21, 2016: Akorn Appoints Greg Lawless as Chief Human Resources Officer 47

Section 6-Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52

List of Figures

Akorn Inc, Performance Chart (2012-2016) 27

Akorn Inc, Ratio Charts 29

Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

Akorn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 32

List of Tables

Akorn Inc, Key Facts 5

Akorn Inc, Key Employees 6

Akorn Inc, Key Employee Biographies 7

Akorn Inc, Major Products and Services 8

Akorn Inc, History 10

Akorn Inc, Subsidiaries 15

Akorn Inc, Joint Venture 15

Akorn Inc, Key Competitors 23

Akorn Inc, Ratios based on current share price 24

Akorn Inc 25

Akorn Inc (Cont...1) 26

Akorn Inc, Interim Ratios 28

Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

Akorn Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Akorn Inc, Recent Deals Summary 33

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Valeant Pharmaceuticals International Inc Teva Pharmaceuticals Ltd Pfizer Inc Perrigo Company Plc Novartis International AG Johnson & Johnson Hikma Pharmaceuticals Plc Fresenius Kabi AG Apotex Inc Allergan Plc

Akorn Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8431
Site License
USD 250 INR 16863
Corporate User License
USD 375 INR 25294



Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com